Mabxience And Amneal Announces FDA Approval Of Denosumab Biosimilars Referencing Prolia® And XGEVA®. mAbxience / Key word(s): Miscellaneous mAbxience and Amneal Announces FDA Approval of Denosumab ...

Approvals expand Amneal's biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027 BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceu ...

Hemophilia increases bleeding risks in pregnancy and delivery. Learn how to manage low clotting factors, postpartum hemorrhage, and more.

Discontinuation of GLP-1 receptor agonists before pregnancy or early during pregnancy was tied to more gestational weight and ...

The burden of maternal cardiometabolic comorbidities and incident pregnancy-related CV complications has increased ...

Before giving birth to her second child, Heidi DiLorenzo was anxious. She worried about her blood pressure and the ...

She had used the medication to treat anxiety before she had her first child, and she continued it throughout that pregnancy ...

Birth control pills, taken alone or paired with the drug metformin, did not raise the risk of metabolic syndrome, a precursor ...

Gut health is closely linked to women’s reproductive wellness. Imbalances can worsen PCOS and endometriosis. Dr Ruhi Jain, an ...